JWH-196

Overview

JWH-196 is a synthetic cannabinoid that acts as a potent agonist at the cannabinoid receptors. It is part of the JWH series of synthetic cannabinoids, which were developed by Dr. John W. Huffman and his team in the 1990s. These compounds are often used in scientific research to study the endocannabinoid system.

Chemical structure of JWH-196

Chemical Structure

JWH-196 is classified as a naphthoylindole, which is a type of synthetic cannabinoid. Its chemical structure includes a naphthalene group attached to an indole core, which is a common feature among many synthetic cannabinoids in the JWH series. The specific chemical formula for JWH-196 is C24H23NO.

Pharmacology

JWH-196 acts as a full agonist at the CB1 and CB2 receptors, which are part of the endocannabinoid system. This system is involved in regulating various physiological processes, including pain, appetite, and mood. The binding affinity of JWH-196 to these receptors is similar to that of THC, the primary psychoactive component of cannabis.

Legal Status

Due to its potential for abuse and lack of medical use, JWH-196, like many other synthetic cannabinoids, is classified as a controlled substance in many countries. The legal status of these compounds can vary significantly between jurisdictions, and they are often subject to drug scheduling laws.

Health Effects

The use of synthetic cannabinoids like JWH-196 can lead to a range of adverse health effects. These may include tachycardia, hypertension, hallucinations, and psychosis. The potency and unpredictable nature of these compounds can make them particularly dangerous compared to natural cannabinoids.

Research Applications

JWH-196 is primarily used in scientific research to study the cannabinoid receptors and the endocannabinoid system. Researchers use these compounds to better understand the physiological and pharmacological effects of cannabinoid receptor activation.

Related Pages

• Synthetic cannabinoids
• JWH series
• Endocannabinoid system
• Cannabinoid receptor